Sri Lanka’s Pharmaceutical Industry Targets US$1.8 Trillion Global Market with Export Expansion Vision

Colombo, The Gulf Observer: Sri Lanka’s pharmaceutical industry is aiming to strengthen its position in the global healthcare market by focusing on export-oriented growth and tapping into the rapidly expanding international pharmaceutical sector, which is valued at around US$1.8 trillion.

Industry stakeholders have highlighted the country’s potential to emerge as a competitive pharmaceutical manufacturing hub by leveraging its skilled workforce, strategic location in the Indian Ocean and growing investment opportunities. The sector is seeking to move beyond domestic supply and expand its footprint in international markets through quality manufacturing, innovation and compliance with global standards.

Sri Lanka’s pharmaceutical ambitions include increasing local production capacity, reducing dependence on imported medicines and developing export capabilities. The industry has identified investment in advanced manufacturing facilities, research and development, regulatory improvements and international certifications as key priorities for achieving long-term growth.

Recent developments indicate growing investor confidence in Sri Lanka’s pharmaceutical sector, with new manufacturing projects and partnerships aimed at enhancing domestic production and supporting future exports. Industry leaders believe such initiatives could help transform the country into a regional pharmaceutical manufacturing centre.

The pharmaceutical sector has also called for stronger policy support, including a stable investment environment, improved regulatory frameworks and measures to encourage innovation. Industry representatives have stressed that strengthening local manufacturing is essential for improving medicine security and creating opportunities in global markets.

Sri Lanka has set ambitious targets for pharmaceutical exports, with authorities working alongside industry stakeholders to improve product quality, obtain international certifications and expand access to overseas markets.

With increasing global demand for medicines and healthcare products, Sri Lanka is positioning its pharmaceutical industry as a key contributor to economic growth, foreign exchange earnings and the country’s transition towards a knowledge-based economy.